INTRODUCTION
Hand, foot and mouth disease (HFMD) is a common infectious disease worldwide. It is caused by various human enteroviruses (HEVs), particularly enterovirus 71 (EV71) and coxsackievirus A16 (CA16). HEVs belong to the genus Enterovirus and the family Picornavirus [Reference Caro1]. HEVs are characterised by single positive-sense 7·4 kb genomes with single open reading frames. HEVs are classified into four species (A–D), in accordance with their sequence similarity, genome organisation and biological properties.
Children, particularly those under 5 years, tend to be more susceptible to HFMD than others. In most cases, the disease is self-limiting. Symptoms of mild disease generally include fever, skin eruptions on the hands and feet, and vesicular eruptions in the mouth. Most people with only these symptoms readily recover [Reference Ooi2]. However, severe cases occasionally occur; they can develop rapidly and can involve central nervous system complications, such as encephalitis, brainstem encephalitis, aseptic meningitis, poliomyelitis-like syndrome and, occasionally, death [Reference Weng3].
The first HFMD case, which occurred in New Zealand in 1957, was caused by CA16. Thereafter, HEVs have been circulating throughout the world. HFMD can spread by direct contact with fluid from blisters, saliva and stools from infected patients [Reference Podin4]. Over the past 20 years, widespread outbreaks have been reported in Asia-Pacific regions [Reference Podin4–Reference Mizuta12]. The occurrence of HFMD throughout mainland China has received unprecedented attention since the first outbreak in 2008 in the city of Fuyang in Anhui Province. From 2008 to 2012, 6 932 150 probable cases of HFMD (267 942 of which were laboratory-confirmed cases) and 737 deaths were reported in mainland China [Reference Xing10]. In addition to this nationwide surveillance data, several Chinese cities have reported on their local epidemical investigations of HFMD [Reference De13–Reference Xu16]. However, most of these studies were cross-sectional or short-term studies that disregarded the minor HEV genotypes associated with HFMD.
The extensive HFMD outbreak in China remains ongoing. However, there have been no investigations of the full spectrum of HFMD pathogens, and no identification of the long-term trends in the circulating HEVs. Thus, the changes in recent years in the epidemiology of the full spectrum of HFMD pathogens in China remain unknown. In this study, the HFMD epidemics from 2008 to 2015 in Xiamen (a coastal city in southeast China with an internationalised port) were investigated, and most of the collected HEVs were identified and genotyped. We aimed to provide comprehensive information on the HFMD epidemics (involving the full spectrum of HFMD pathogens) in Xiamen to facilitate the prevention and control of HFMD epidemics and the development of diagnostic assays and vaccines.
METHODS
Study area
Xiamen is a medium-sized city in China with large migrant population from both within China and overseas (Fig. 1). It has a population of 4 million and consists of six administrative districts: Siming, Haicang, Huli, Jimei, Tong'an and Xiang'an. Siming and Huli are commercial urban districts with the highest population density; Haicang, Jimei and Xiang'an are industrial suburban districts where a large number of migrant workers live and work; and Tong'an is a rural district with the lowest population density.
Fig. 1. Location of Xiamen in China.
Case definitions and sample collection
According to the Guidelines on the Diagnosis and Treatment of HFMD issued by the National Health and Family Planning Commission of the People's Republic of China, a clinically diagnosed case is defined as a case involving maculopapular or vesicular eruptions on hands, feet, mouth or buttocks, with or without fever. A laboratory-confirmed case is defined as a HEV case confirmed by nucleotide testing, virus isolation or neutralisation testing. A severe HFMD case is defined as a case with neurological complications (i.e. lethargy, startle, vomiting, coma, limb shaking, acute flaccid paralysis, aseptic encephalitis, aseptic meningitis or brainstem encephalitis) or cardiopulmonary complications (i.e. rapid or slow heart rate, cardiopulmonary failure, myocarditis, pulmonary oedema or pulmonary haemorrhage).
As HFMD has been classified as a class C notifiable infectious disease since 2008, all HFMD cases diagnosed in Xiamen have been reported to the Xiamen Centre for Disease Control and Prevention (CDC). In addition, throat swab samples of the first 10 clinically diagnosed patients who visited the outpatient department at each of the 12 sentinel hospitals in Xiamen were collected every month and sent to the Xiamen CDC in sterile viral transport medium. (If there were fewer than 10 patients, all the patients were sampled.) Furthermore, samples from all the severe cases were collected.
Since January 2009, samples have also been sent to our laboratory, the State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, for aetiological determination. In total, we assessed 5866 specimens between January 2009 and September 2015.
RNA extraction and nested reverse transcription PCR (nRT-PCR)
The viral RNA was extracted from the samples using GenMagSpin Viral DNA/RNA Isolation Kits (GenMag Biotechnology Co., Ltd., Beijing, China), in accordance with the manufacturer's instructions.
The samples were examined using nRT-PCR, in accordance with our previously reported method [Reference Ge17]. Briefly, the specimens were first tested using sets of broad-spectrum primers for the HEV-5′ untranslated region (UTR) and specific primers for the EV71-viral protein 1 (VP1) and CA16-VP1 simultaneously. The samples that were positive for the 5′ UTR but negative for EV71-VP1 and CA16-VP1 were then amplified using additional genotype-specific primers for the VP1 region. Finally, all of the amplicons for the VP1 regions were subjected to further sequencing and genotyping. The primers used for genotyping are shown in Supplementary Tables S1 and S2.
Genotyping by phylogenetic analysis
Multiple sequence alignments were constructed using MEGA software version 5.0 and the Clustal W program. To determine nucleotide similarities, we compared the sequences with standard strains from GenBank (US National Centre for Biotechnology Information).
Phylogenetic trees were constructed using a neighbour-joining cluster algorithm, with evolutionary distances estimated using the Kimura two-parameter model; bootstrapping was performed using 1000 pseudo-replicates [Reference Savolainen-Kopra18].
RESULTS
HFMD incidence rates and age and gender distribution of HFMD cases
From January 2008 to June 2015, 27 227 cases of HFMD were reported to the Xiamen CDC, including 99 severe cases and six deaths. The mean HFMD incidence rate from 2008 to 2014 in the general population in Xiamen was 934·3/1 000 000. The annual HFMD incidence rates (Table 1) increased between 2009 and 2014 (from 305·2/1 000 000 to 1713·4/1 000 000), but the first peak occurred in 2010, with a rate of 1183·1/1 000 000. During 2008–2014, the mean incidence rate of severe cases was 3·1/1 000 000, and the mean mortality rate was 0·27/1 000 000.
Table 1. Incidence, severe illness and mortality rates associated with HFMD cases in Xiamen from January 2008 to December 2014
HFMD, hand, foot and mouth disease.
The HFMD incidence rate varied considerably with age and gender. Cases involving those aged <1, 1, 2, 3, 4, 5, 6–9 and >9 years accounted for 8·83%, 27·59%, 22·51%, 18·31%, 10·89%, 5·45%, 4·73% and 1·47% of the total cases, respectively. The highest incidence rate was found in those aged 1, and children under 5 years accounted for 93·8% of cases. There were more male patients than female patients, with a male-to-female ratio of 1·66:1, but there was no difference in the age distribution between male and female patients (Supplementary Fig. S1). The age and gender distributions of the severe cases were similar to those overall.
Temporal distribution of HFMD cases
The highest number of HFMD cases in Xiamen during the study period was in 2014, and the lowest was in 2009. From 2009 to 2014, with the exception of 2010, the number of HFMD cases increased annually (Fig. 2a). However, 45·6% of the severe cases from 2009 to 2014 were reported in 2010 (Fig. 2b) and 50% of the deaths from 2009 to 2014 were reported in 2012.
Fig. 2. Temporal distribution of overall and severe HFMD cases in Xiamen from January 2008 to September 2015. (a) Overall and (b) severe HFMD cases by month.
In Xiamen, there was an annual HFMD incidence rate peak in spring and early summer in 2008, 2010, 2011, 2012, 2013, 2014 and 2015, with an additional small peak in the winter of 2012 and an additional large peak in 2014 and 2015. Unlike in the other years, the monthly HFMD incidence rates in 2009 were low and steady, with no peaks (Fig. 2a).
The seasonal distributions were consistent between cases overall and severe cases. Each year, 74·7% of the severe cases were reported in spring and early summer (Fig. 2b).
Geographical distribution of HFMD cases
The incidence rate differed greatly between the six districts of Xiamen (Fig. 3). The incidence rates in Haicang, Jimei and Xiang'an were significantly higher than the mean incidence rate, and those in Siming and Huli were below the mean, while Tong'an had the lowest incidence rate of all the districts. However, the incidence rate of severe HFMD cases in Tong'an was significantly higher than the mean, while the incidence rates of severe HFMD cases in Haicang and Xiang'an were slightly above those in Siming, Huli and Jimei (Fig. 3).
Fig. 3. Annual incidence rates of overall HFMD cases in Xiamen, and Siming, Haicang, Huli, Jimei, Tong'an and Xiang'an districts from 2008 to 2014.
Clinical manifestations in severe HFMD cases
For the 99 severe cases and six cases involving deaths, the most common symptoms were fever and maculopapular and vesicular eruptions (Table 2). Central nervous system complications such as convulsions and limb shaking were also common. Some of these cases also involved cardiopulmonary complications.
Table 2. Symptoms of the 99 severe HFMD cases and the six cases involving death
HFMD, hand, foot and mouth disease.
Pathogen identification
Since January 2009, throat swab samples from patients with HFMD have been sent to our laboratory, the State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, for further study. Some specimens were excluded due to lack of background information, such as the patient's age and sex, and the onset of HFMD and sampling dates. In total, we analysed data on 5866 cases, which included 3669 male and 2197 female patients.
An overview of the HFMD cases detected in our laboratory is shown in Supplementary Table S3. The mean age was 2·47 ± 2·67 years, and the male-to-female ratio was 1·67:1, which is consistent with the statistics for the overall HFMD cases in Xiamen. This suggested that the throat swab samples were a good representation of the cases overall.
Of the 5866 specimens, 4290 were HEV-positive (73·1%). Most of the HEV genotypes in these HEV-positive cases were identified, except for 167. The majority of pathogens belonged to species A, including EV71, CA16 and coxsackieviruses A6 and A10 (CA6 and CA10). The others belonged to species B, and coxsackievirus B3 (CB3) accounted for the largest proportion.
Our data show that the major HFMD pathogen changed periodically over the study period from January 2009 to September 2015. The full spectrum of HFMD pathogens per quarter is presented in Fig. 4a, and the four most common HEV species in each year (which accounted for >90% of HFMD cases in each year) are shown in Table 3. EV71 was always one of the most predominant HEVs (it ranked first in 2010, 2012 and 2014, and second in the other years).
Fig. 4. Full spectrum of HFMD pathogens in Xiamen from January 2009 to September 2015. (a) Overall HFMD cases by quarter and (b) severe HFMD cases by year.
Table 3. Four most common HEV genotypes identified in HFMD cases in Xiamen from 2009 to 2015
HEV, human enterovirus; HFMD, hand, foot and mouth disease; EV, enterovirus; C, coxsackievirus.
CA6 replaced CA16 from 2012 onwards as one of the top two HEV genotypes. CA16 accounted for 71·8% of HFMD cases in 2009, but the proportion decreased over time (it was about 30% in 2010 and 2011, 10–20% from 2012 to 2014, and only 6·38% in 2015). Meanwhile, the proportion of CA6 increased from about 3% in 2009 and 2010 to 20% in 2011 and 2012, and 59·6% in 2013 (when it became the most predominant genotype). Although CA10 was never the most predominant genotype, it was always among the four most common HEVs except in 2014. In 2014, CA4, rather than CA10, ranked fourth.
In addition to the four most common HEVs (EV71, CA16, CA6 and CA10), we also detected other HEVs circulating at lower levels (Supplementary Table S4). These pathogens belonged to species A and B. No genotypes belonging to species C or D were identified.
For the severe cases, the major HFMD pathogens did not change periodically (Fig. 4b). EV71 was responsible for 78·08% of the severe cases, CA16 for 4·11%, CA10 for 9·59%, and other HEVs for 8·22%. None of the severe cases were caused by CA6. All the cases involving death were caused by EV71.
There was no significant difference in the age distribution (Supplementary Fig. S2) or male-to-female ratio between the genotype-specific cases and the cases overall. For each genotype, >70% of cases were found in children aged 0·5–4 years, i.e. 71·9% of EV71 cases, 88·5% of CA16 cases, 93·8% of CA6 cases, 91·4% of CA10 cases and 86·5% of the other cases. However, CA6 and CA10 were more likely to affect younger children (⩽2 years) than EV71 and CA16 (Supplementary Fig. S2).
Phylogenetic analysis of major pathogens
Phylogenetic analysis revealed that the predominant lineages of EV71, CA16, CA6 and CA10 did not change from 2009 to 2015 (Supplementary Figs S3–S7). Based on the partial VP1 sequences, almost all the EV71 strains clustered in sub-genogroup C4a, though a few strains in the B5, C2 and C5 genogroups were also identified (Supplementary Fig. S3).
We only performed a phylogenetic analysis of CA16 strains isolated from 2009 to 2012 because these strains caused milder symptoms and there was a significant reduction in CA16 cases from 2013 onwards. Based on the partial VP1 sequences, the CA16 strains were divided into two sub-genogroups, B1a and B1b (Supplementary Fig. S4), and B1b was the predominant lineage (Supplementary Fig. S5).
The complete VP1 sequences of CA6 and CA10 were analysed. The vast majority of CA6 strains clustered in genogroup A, though some strains isolated in 2010–2013 clustered in genogroups B and D (Supplementary Fig. S6). Almost all the CA10 strains belonged to one lineage in genogroup A, though some strains isolated in 2015 belonged to a new lineage in genogroup A (Supplementary Fig. S7).
Phylogenetic analysis of EV71 VP1 sequences showed that strains isolated from severe or mild cases were dispersed in one sub-cluster, with a high degree of homology. Phylogenetic analysis of CA16 and CA10 strains isolated from severe and mild cases led to similar results to those for the EV71 strains.
DISCUSSION
In addition to the analysis of 2008–2015 data on all the 27 227 clinical HFMD cases diagnosed in local hospitals that were reported to Xiamen CDC, almost all the HEV strains collected during 2009–2015 from the sentinel hospitals were successfully identified and genotyped. Based on these data, we were able to comprehensively investigate the HFMD epidemics and the molecular epidemiology of HEVs in Xiamen.
As a result of Xiamen's geographic location and high degree of population mobility, the HFMD epidemic in Xiamen may be similar to or different from other areas of China. The age and gender distributions of HFMD in Xiamen were similar to those in other areas of China [Reference Chen5, Reference Xu16, Reference Lo19–Reference Liu23]. However, the temporal distribution in Xiamen exhibited unique characteristics. There was one annual outbreak (peaking in June) in northern China, and two annual outbreaks (peaking in May and October) in southern China [Reference Xing10, Reference Liu24]. In Xiamen, the temporal distribution was mixed, with one outbreak peak in 2008–2011 and 2013, and two in 2012, 2014 and 2015. In 2012, the first outbreak peak occurred in the spring and early summer, followed by an additional smaller peak in the autumn. However, in 2014 and 2015, after the first large peak in May, another large peak occurred in the autumn. This may be attributable to the combined effects of the climatic, demographic and virus virulence factors in Xiamen.
In addition, although the HFMD incidence rates in southern and eastern China were significantly higher than those in western, northeastern and northern China [Reference Xing10, Reference Liu24], the incidence rates in Xiamen were lower than the national rates from 2009 to 2013 (though the 2008 rate in Xiamen was higher than the national rate, while the national rates for 2014 onwards have not yet been reported). This might be because the percentage of susceptible individuals in Xiamen is lower than the national percentage.
Interestingly, the incidence rates in different districts of Xiamen varied. Although the urban districts, Siming and Huli, have much higher population densities and a much higher degree of migration, the incidence rates in these districts were lower than in the other districts, most likely because of their better health systems. Tong'an, the only rural districts in Xiamen, also had a low incidence rate, perhaps because its lower population density and rate of migration limited the spread of the disease. The industrial suburban districts, Haicang, Xiang'an and Jimei, have large migrant populations and relatively poor sanitary conditions, which resulted in the high incidence rates in these districts. These findings indicate that crowding and poor sanitation are risk factors for HFMD. However, Tong'an had the highest incidence rates of severe HFMD. This could be due to its relatively underdeveloped health system and medical conceptions.
Most previously published epidemiological studies on HFMD conducted in China have been short-term or cross-sectional surveys that have focused only on EV71 and CA16 [Reference Li25–Reference Zhang27]. Therefore, little is known about the long-term epidemical trends of HFMD pathogens in China. In this study, we used a new strategy to detect and genotype the full spectrum of HEVs that cause HFMD (based on our previous work [Reference Ge17]), and we analysed data on the full spectrum of HFMD pathogens that circulated in Xiamen over a period of 7 years. The data indicate that there have been cyclical epidemics involving annual changes in the predominant pathogens, namely, CA16 in 2009 and 2011, EV71 in 2010, 2012 and 2014, and CA6 in 2013 and 2015. A similar phenomenon to that involving the predominance of EV71 every 2 years in Xiamen has been observed in Taiwan, where EV71 epidemics have appeared periodically every 2–3 years [Reference Wu7]. Herd immunity and supplement of susceptible population may explain these patterns.
In 2013 in Xiamen, the proportion of CA16 cases sharply declined (so that CA16 was no longer one of the top two HEVs), while the proportion of CA6 cases rapidly increased. The reason for this is unclear. It cannot be explained simply by herd immunity or altered infectivity due to viral mutations. In this period, the predominant EV71 lineage had been widely circulating for a long time and yet it remained in the top two genotypes. In addition, compared with the predominant CA16 and CA6 lineages isolated before 2013, no characteristic mutations in the predominant CA16 and CA6 lineages were identified since 2013. CA6 has accounted for a growing percentage of HFMD cases in Xiamen in recent years, a phenomenon that has also been observed in many other areas of China [Reference Zeng28–Reference Chen32]. Most cases caused by CA6 have been self-limiting, and severe HFMD cases have not been reported among individuals infected with CA6 [Reference Huang20, Reference Feder, Bennett and Modlin33].
Although some EV71 strains belonging to sub-genogroups B5, C2 and C5 were identified, the EV71 sub-genogroup C4a was always the predominant lineage in Xiamen. This is very different from the situation in Taiwan, despite Xiamen and Taiwan being located on opposite sides of the Taiwan Strait, and the high degree of migration between them. In Taiwan, EV71 reoccurred every 2–3 years as the predominant HEV strain, which was always accompanied by a lineage change, e.g. B4 in 2002, C4 in 2004–2005, B5 in 2008–2009, C4 in 2010 and B5 in 2011–2012 [Reference Wu7]. The difference may have occurred because the susceptible population in mainland China is larger than in Taiwan, and so EV71 was under less herd immunity-related selective pressure in mainland China. Moreover, it could be speculated that the C4a has competitive advantages compared with other EV71 sub-genogroups, such as higher infectivity.
The VP1 sequences of EV71, CA16 and CA10 strains that cause mild and severe disease were highly homologous. Possible reasons for the different clinical phenotypes are as follows: (1) nucleotide and amino acid changes in non-VP1 sequences might augment the virulence of HEVs [Reference Zhong34, Reference Huang35] and (2) differences in individual immunity might be the driver of the different clinical manifestations.
Our study indicates that the HEVs associated with HFMD cocirculating in Xiamen are highly diverse, which is likely to be similar to the situation in other areas of mainland China. Besides EV71, CA16 and CA6, we detected five HEV genotypes of species A and 14 of species B (Supplementary Table S4), which had largely been disregarded in most surveillance studies of HFMD-associated HEVs conducted in mainland China. It is possible that one or more HEV species from among the minor circulating pathogens will become predominant in the future, as CA6 did in 2013. In addition, it is noteworthy that some of them, such as CB3 and CA10, can cause severe HFMD. In particular, the proportion of severe cases among CA10-infected patients increased significantly over the course of the study period, and this was accompanied by the occurrence of a new lineage in 2015 (the data have not yet been reported). We recommend that non-EV71 and non-CA16 HEVs should be comprehensively identified, and studies on the molecular epidemiology of HEVs should be conducted as part of routine surveillance of HFMD. This would provide useful epidemical information, and facilitate the development of diagnostic assays and vaccines for HFMD.
In summary, we reported on the HFMD epidemics in Xiamen over the past 8 years, and elucidated the full spectrum of HEVs associated with HFMD and the molecular epidemiology of these HEVs. This is the first long-term longitudinal study on HFMD epidemics involving the identification of HFMD-associated HEVs in a specific administrative region in China. The findings provide comprehensive information for understanding the ongoing HFMD epidemics in mainland China, and will be of value in the development of effective strategies for HFMD prevention and control.
SUPPLEMENTARY MATERIAL
The supplementary material for this article can be found at https://doi.org/10.1017/S0950268817000309
ACKNOWLEDGEMENTS
This study was supported by the Natural Science Foundation of Fujian Province (Grant numbers 2013J06016 and 2015J05073); and the Scientific and Technological Innovation Platform of Fujian Province (Grant number 2014Y2004).
DECLARATION OF INTEREST
None.
